thiazolidines has been researched along with Rhabdomyosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, C; Hettmer, S; Regina, C; Schneider, M; Tchessalova, D; Wagers, AJ; Würtemberger, J | 1 |
| Astre, C; Joyeux, H; Possompes, B; Recasens, MA; Saint Aubert, B | 1 |
2 other study(ies) available for thiazolidines and Rhabdomyosarcoma
| Article | Year |
|---|---|
Growth inhibition associated with disruption of the actin cytoskeleton by Latrunculin A in rhabdomyosarcoma cells.
Topics: Actin Cytoskeleton; Animals; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Mice; Rhabdomyosarcoma; Thiazolidines | 2020 |
Thiazolidine-4-carboxylate and 2-phenylthiazolidine-4-carboxylate are active as cysteine precursors but have no effect on growth of a methionine-dependent tumor in rats.
Topics: Amino Acids; Animals; Antineoplastic Agents; Body Weight; Cysteine; Glutathione; Male; Methionine; Rats; Rats, Inbred Strains; Rhabdomyosarcoma; Thiazoles; Thiazolidines | 1992 |